US biopharming business sets off new GM contamination episode

The biotechnology industry was immersed in a new controversy in November when the first incidents involving contamination of food crops by plants which had been genetically modified to produce pharmaceuticals came to light in the US. The affair has set biotech businesses against food manufacturers and underlined the huge difficulties ahead in safeguarding the food chain as the GM revolution advances.

Sign in to continue

Sign in

Trouble signing in?

Reset password: Click here


Call: 020 8267 8120

Take a 30-day trial

  • Join ENDS Report now and pay nothing for your first 30-days.



Prices on request

  • Full access to for 12 months
  • Clear and accessible guidance on relevant legislation
  • Integration with ENDS Compliance Manager helping you plan ahead and ensure compliance for your organisation
  • Individual or bespoke multi-user packages available

See all benefits

Need to activate your subscription?
Already a subscriber
If you haven't already, activate your subscription here>>
Company Domain Access
If your company or university has a corporate subscription simply register your email address here to gain access